Transmission/disequilibrium tests of androgen receptor and glutathione S-transferase pi variants in prostate cancer families

Gloria Y.F. Ho, Michael Knapp, Diha Freije, William G. Nelson, Jeffrey R. Smith, John D. Carpten, Joan E. Bailey-Wilson, Terri H. Beaty, Gloria Petersen, Jianfeng Xu, Victor Kamensky, Patrick C. Walsh, William B. Isaacs

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Population-based case-control studies have found relationships between risk of prostate cancer and genetic polymorphisms in the CAG repeat and GGC repeat of the X-linked androgen receptor gene (AR) as well as the autosomal gene coding for glutathione S-transferase pi (GSTPI). This family-based study utilized the transmission disequilibrium test to examine whether there was evidence that these polymorphisms could account for familial aggregation of prostate cancer. Seventy-nine North American pedigrees were studied. Most of these families had 3 or more affected first-degree relatives. Genotype information was obtained on 578 individuals. The reconstruction combined transmission disequilibrium test (RC-TDT) was used to test for linkage. There was no evidence of linkage to the CAG and GGC repeat sequences in the AR gene or the pentanucleotide (ATAAA) repeat in the GSTPI gene when each allele was analyzed separately or when alleles were grouped by repeat length. Our findings do not support the hypothesis that familial clustering of prostate cancer in high-risk families is attributable to these genetic variants.

Original languageEnglish (US)
Pages (from-to)938-942
Number of pages5
JournalInternational Journal of Cancer
Volume98
Issue number6
DOIs
StatePublished - Apr 20 2002

Keywords

  • Androgen receptor
  • Glutathione S-transferase pi
  • Prostate cancer
  • Transmission disequilibrium test

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Transmission/disequilibrium tests of androgen receptor and glutathione S-transferase pi variants in prostate cancer families'. Together they form a unique fingerprint.

Cite this